Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bingchen Xu
Observed names:
B S Xu,
Bing-Chen Xu
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China,
Inner Mongolia Medical University
Observed institutions:
Sun Yat-sen University,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China,
Inner Mongolia Medical University
ORCID:
0000-0002-4885-5142
Observed ORCID:
0000-0002-4885-5142
OpenAlex ID:
A5016541663
Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers
2021
·
Ying Zhu
, Wang Yao
, et al.
·
BMC Cancer
·
40
PDF
The role of immune regulation in HBV infection and hepatocellular carcinogenesis
2025
·
Hailong Zheng
, Bingchen Xu
, et al.
·
Frontiers in Immunology
·
29
Hydrogen‐Generating Magnesium Alloy Seed Strand Sensitizes Solid Tumors to Iodine‐125 Brachytherapy
2024
·
Pan Hu
, Letao Lin
, et al.
·
Advanced Science
·
13
PDF
MEOX2 serves as a novel biomarker associated with macrophage infiltration in oesophageal squamous cell carcinoma and other digestive system carcinomas
2021
·
Zhen Wang
, Han Yang
, et al.
·
Autoimmunity
·
10
Gut Microbiota, Human Blood Metabolites, and Esophageal Cancer: A Mendelian Randomization Study
2024
·
Xiuzhi LI
, Bingchen Xu
, et al.
·
Genes
·
6
PDF
Comparison of Outcomes Between Ablation and Lobectomy in Stage IA Non‐Small Cell Lung Cancer: A Retrospective Multicenter Study
2025
·
Bingchen Xu
, Zhixian Chen
, et al.
·
Respirology
·
5
Exploring the Mediation Effect of Metabolite Levels on the Association Between Gut Microbiota and HCC: A two-step, two-sample bidirectional Mendelian Randomization
2024
·
Bingchen Xu
, Lianxin Zhu
, et al.
·
Journal of Cancer
·
4
PDF
Ablation versus sublobar resection for stage IA non-small cell lung cancer: a multicenter retrospective cohort study using a deep learning model in the ablation group
2025
·
Bingchen Xu
, Dongcun Huang
, et al.
·
International Journal of Surgery
·
2
Development and validation of a nomogram for predicting survival time and making treatment decisions for clinical stage IA NSCLC based on the SEER database
2022
·
Bingchen Xu
, Ziming Ye
, et al.
·
Frontiers in Medicine
·
2
PDF
[Single-center study of different treatment for advanced or unresectable angiosarcoma patients].
2023
·
R Q Peng
, B S Xu
, et al.
·
PubMed
·
1
Mechanism of miR-217 in suppressing pancreatic cancer progression by targeting ENO1
2026
·
Junwei Du
, Yang Liu
, et al.
·
Discover Oncology
Liver metastasis ablation combined with PD ‐1 inhibitors improves immunotherapy efficacy: A multicenter cohort study
2026
·
Dengyao Liu
, Bingchen Xu
, et al.
·
International Journal of Cancer
Survival Outcomes, Cost-Effectiveness Analysis and Prognostic Model of Image-Guide Thermal Ablation Versus Sublobar Resection for Stage Ia Non-Small-Cell Lung Cancer: A Multi-Center Retrospective Cohort Study
2025
·
Bingchen Xu
, Tao Huang
, et al.
·
SSRN Electronic Journal
PD-1 inhibitor combined with ablation in liver metastasis: A retrospective, multicenter study.
2024
·
Dengyao Liu
, Tao Huang
, et al.
·
Journal of Clinical Oncology
Predicting Response to Immunotherapy Plus Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma Using Non-Invasive Radiomic Biomarkers
2021
·
Ying Zhu
, Wang Yao
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
15
Citation count:
112
H-index:
5
I10-index:
4
Year
Topic
Type